Relative Strength Review: Taking a Look at Shares of Sinopharm Group (SHTDY)

The momentum-investing technique that compares the performance of a commodity to that of the overall market is called Relative Strength.  Through specific calculations, investors and traders target the strongest performers as compared to the overall market, thus creating recommendations for investments.  Relative strength assumes a commodity whose price has been rising recently will continue to rise.  Relative strength creates a point of comparison between the performance of a security and the performance of other similar securities and other benchmarks.  All investors who use relative strength will have entry and exit strategies.  Traders and investors who use relative strength attempt to buy securities that show signs of strength while selling them when they begin to weaken.  Relative strength is also applied to more complex strategies.  Investors use relative strength to identify big performers within a group, comparing the performance of each security directly to another security or to a specific benchmark index like the S&P 500.  Sinopharm Group (SHTDY)’s 9-Day Relative Strength is 46.25%.  Its 14-Day Relative Strength is 48.26% and its 20-Day Relative Strength is 49.13% while its 50-Day Relative Strength is 49.13%.  Lastly, its 100-Day Relative Strength is 49.74%.

Weighted Alpha is a measure of how much a stock has risen or fallen over a one-year period with a higher weighting for recent price activity.  Sinopharm Group (SHTDY)’s Weighted Alpha is -2.41.

Sinopharm Group (SHTDY)’s TrendSpotter Opinion, the signal from Trendspotter, a Barchart trend analysis system that uses wave theory, market momentum & volatility in an attempt to find a general trend, is Buy. 

The Open is the start of trading on a securities exchange.  The open indicates the start of an official business day for an exchange, meaning that transactions may begin for the day.  The different exchanges have different opening times.  Sinopharm Group (SHTDY) opened at $22.644.  Its high for the day was $22.69, its low was $22.24 and last trade price was $22.24. 

Standard Deviation is a measure of the current average variability of return.  A move of (plus or minus) 1 std deviation means a 33% odds for a major price move, whereas a move of (plus or minus) 3 std deviations means a 1% odds for a major price move.  Sinopharm Group (SHTDY)’s Standard Deviation is -2.33.

Relative Strength is part of technical analysis.  Technical analysis is a trading tool used to judge securities as well as attempt to forecast their future moves by analyzing trading activity statistics like volume and price fluctuations.  Where fundamental analysts attempt to evaluate the intrinsic value of a security, technical analytics observe charts of price movements and forecast future price movements through various analytical tools to evaluate a security’s strength or weakness. 

Technical analysts believe in the idea that price changes of a security and past trading activity are better indicators of that given security’s future price movements than simply the intrinsic value of said security.  Technical analysis was created out of simple concepts learned from Dow Theory, the theory of trading market movements that originated from the early writings of Charles Dow.  The two basic assumptions of Dow Theory say analysis are: 1.) market price discounts all the factors that could influence a security’s price and: 2.) market price movements are not simply random but move in an identifiable pattern and that repeat over time.

The first assumption, that price discounts everything, means the market price of a commodity at any given point in time perfectly reflects all available information, and re represents the security’s true fair value.  It is based on the idea the market price always reflects the sum total knowledge of the market.  The second basic assumption, the notion that price changes are not just random, leads to the belief that both short term and long term market trends can be identified, allowing traders to profit from investing when following the existing trend.  Technical analysis is used in order to forecast the price movement of all tradable instruments that are subject to the forces of supply and demand, including currency pairs, bonds, stocks, and futures.  Technical analysis can be viewed simply as the study of supply and demand as reflected in market price movements of securities.  It is usually applied to price changes, though analysts may also track numbers other than price, such as open interest figures or trading volume.  Many technical indicators have been developed by analysts over the years in an attempt to forecast future price movements accurately. Some indicators are focused on determining the how strong a trend is and also the possibility of its continuation while other indicators focus on identifying current market trends, including resistance areas and support.  Commonly used technical indicators include moving averages, trendlines, and momentum indicators like the moving average convergence divergence (MACD) indicator.

Technical analysts apply these indicators to charts of differing timeframes.  Short-term traders may use charts covering one-minute timeframes to hourly or even four-hour timeframes, and traders analyzing more long-term price movements look over daily, weekly or monthly charts.

Barchart Opinions show investors what a variety of popular trading systems are suggesting.  These Opinions take up to 2 years’ worth of historical data and runs the prices through thirteen technical indicators.  After each calculation, a buy, sell or hold value for each study is assigned, depending on where the price is in reference to the interpretation of the study.  Today’s opinion, the overall signal based on where the price lies in reference to the common interpretation of all 13 studies, for Sinopharm Group (SHTDY) is 16% Sell.

Disclaimer: The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs.  Where quoted, past performance is not indicative of future performance.">(function($){$(document).ready(function(){});})(jQuery);